Agile Therapeutics | AGRX - Net Income

Agile Therapeutics reported $-19666000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Net Income Change
Adma Biologics ADMA:US USD -14900000 1.14M
Bayer BAYN:GR EUR 611M 65M
Biomarin Pharmaceutical BMRN:US USD -249000 6.4M
JAZZ PHA JAZZ:US USD -240724000 221.08M
Johnson & Johnson JNJ:US USD 3.52B 938M
Merk MRK:US USD 3.02B 231M
Pacira Pharmaceuticals PCRX:US USD -10102000 9.41M
Pfizer PFE:US USD 5B 3.61B
Teva Pharmaceutical Industries TEVA:US USD -1222000000 1.28B
Therapeuticsmd TXMD:US USD -28965000 141.25M